Baxter Current Ratio 2010-2025 | BAX

Current and historical current ratio for Baxter (BAX) from 2010 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Baxter current ratio for the three months ending March 31, 2025 was 2.02.
Baxter Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2025-03-31 $7.04B $3.48B 2.02
2024-12-31 $8.85B $6.51B 1.36
2024-09-30 $8.86B $6.20B 1.43
2024-06-30 $8.59B $6.13B 1.40
2024-03-31 $9.40B $6.37B 1.48
2023-12-31 $9.60B $6.50B 1.48
2023-09-30 $12.03B $6.21B 1.94
2023-06-30 $8.21B $5.77B 1.42
2023-03-31 $8.10B $4.76B 1.70
2022-12-31 $8.01B $4.75B 1.69
2022-09-30 $7.81B $3.71B 2.11
2022-06-30 $7.88B $3.92B 2.01
2022-03-31 $8.17B $3.89B 2.10
2021-12-31 $8.87B $4.24B 2.09
2021-09-30 $8.17B $3.44B 2.37
2021-06-30 $8.00B $3.34B 2.39
2021-03-31 $7.86B $3.19B 2.47
2020-12-31 $8.41B $3.33B 2.52
2020-09-30 $9.03B $3.42B 2.64
2020-06-30 $8.57B $2.88B 2.97
2020-03-31 $8.33B $3.04B 2.75
2019-12-31 $7.50B $3.23B 2.32
2019-09-30 $7.21B $2.61B 2.76
2019-06-30 $7.22B $2.60B 2.78
2019-03-31 $6.09B $3.33B 1.83
2018-12-31 $5.96B $2.81B 2.12
2018-09-30 $7.03B $2.70B 2.60
2018-06-30 $6.89B $2.63B 2.62
2018-03-31 $6.96B $2.64B 2.63
2017-12-31 $7.26B $2.82B 2.58
2017-09-30 $7.45B $2.66B 2.80
2017-06-30 $7.70B $2.56B 3.01
2017-03-31 $6.63B $2.44B 2.72
2016-12-31 $6.57B $2.74B 2.40
2016-09-30 $6.59B $2.61B 2.53
2016-06-30 $6.82B $3.72B 1.83
2016-03-31 $8.02B $3.82B 2.10
2015-12-31 $11.80B $5.75B 2.05
2015-09-30 $11.14B $5.98B 1.86
2015-06-30 $14.50B $6.31B 2.30
2015-03-31 $9.73B $6.07B 1.60
2014-12-31 $10.16B $6.04B 1.68
2014-09-30 $9.63B $5.99B 1.61
2014-06-30 $9.49B $5.80B 1.64
2014-03-31 $9.39B $5.65B 1.66
2013-12-31 $10.20B $5.25B 1.94
2013-09-30 $9.60B $5.00B 1.92
2013-06-30 $12.19B $4.52B 2.70
2013-03-31 $8.81B $4.78B 1.85
2012-12-31 $9.26B $4.76B 1.95
2012-09-30 $9.11B $4.46B 2.04
2012-06-30 $8.05B $4.87B 1.65
2012-03-31 $8.12B $4.86B 1.67
2011-12-31 $8.65B $4.86B 1.78
2011-09-30 $8.00B $4.17B 1.92
2011-06-30 $7.81B $4.03B 1.94
2011-03-31 $7.76B $3.89B 2.00
2010-12-31 $7.99B $4.04B 1.98
2010-09-30 $8.14B $4.20B 1.94
2010-06-30 $7.38B $4.09B 1.81
2010-03-31 $8.02B $4.28B 1.87
2009-12-31 $8.27B $4.46B 1.85
2009-09-30 $8.06B $3.47B 2.33
2009-06-30 $7.07B $3.40B 2.08
2009-03-31 $6.69B $3.12B 2.14
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $14.764B $10.636B
Baxter International Inc. is a global medical technology company. The company consists of renal and hospital products, providing items such as kidney-dialysis equipment, infusion pumps, and intravenous (IV) solutions. Baxter has been reporting through six revenue segments. Renal Care, Medication Delivery, Pharmaceuticals, Clinical Nutrition, Advanced Surgery, Acute Therapies and Other. Baxter's Renal segment primarily consists of Peritoneal Dialysis (PD) and Hemodialysis (HD) therapies. The portfolio addresses the needs of patients with kidney failure or kidney disease, and their healthcare providers, with a comprehensive range of therapeutic options across home, in-center, and hospital settings for better individualized care.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $218.593B 25.64
Boston Scientific (BSX) United States $157.132B 37.53
Stryker (SYK) United States $151.401B 31.66
EssilorLuxottica (ESLOY) France $135.007B 0.00
Medtronic (MDT) Ireland $118.404B 16.78
Lonza Group Ag (LZAGY) Switzerland $49.975B 0.00
Haleon (HLN) United Kingdom $44.249B 25.26
ResMed (RMD) United States $40.103B 30.12
GE HealthCare Technologies (GEHC) United States $35.152B 16.69
Agilent Technologies (A) United States $34.187B 22.29
Terumo (TRUMY) Japan $25.999B 33.77
Koninklijke Philips (PHG) Netherlands $24.882B 17.46
Insulet (PODD) United States $20.168B 79.17
Zimmer Biomet Holdings (ZBH) United States $19.166B 12.31
Smith & Nephew SNATS (SNN) United Kingdom $13.788B 0.00
Sunny Optical Technology (SNPTF) China $10.417B 0.00
Demant (WILYY) Denmark $8.633B 0.00
Bio-Rad Laboratories (BIO) United States $7.131B 24.82
Lantheus Holdings (LNTH) United States $4.907B 12.38
Perrigo (PRGO) Ireland $3.864B 9.79
Prestige Consumer Healthcare (PBH) United States $3.769B 16.84
Haemonetics (HAE) United States $3.568B 16.25
Envista Holdings (NVST) United States $3.503B 29.11
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
ICU Medical (ICUI) United States $3.180B 23.45
LeMaitre Vascular (LMAT) United States $1.825B 40.79
QuidelOrtho (QDEL) United States $1.781B 12.25
AtriCure (ATRC) United States $1.494B 0.00
Acuren (TIC) United States $1.450B 0.00
Green Thumb Industries (GTBIF) United States $1.268B 28.52
AdaptHealth (AHCO) United States $1.244B 12.63
Phibro Animal Health (PAHC) United States $1.193B 15.25
Neogen (NEOG) United States $1.111B 14.22
BioLife Solutions (BLFS) United States $1.065B 0.00
InMode (INMD) Israel $0.918B 9.25
Kestra Medical Technologies (KMTS) United States $0.871B 0.00
Curaleaf Holdings (CURLF) Canada $0.851B 0.00
Tilray Brands (TLRY) Canada $0.707B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.690B 0.00
Valneva SE (VALN) France $0.646B 0.00
Evolus (EOLS) United States $0.622B 0.00
Owens & Minor (OMI) United States $0.613B 5.09
CeriBell (CBLL) United States $0.556B 0.00
ZimVie (ZIMV) United States $0.522B 23.71
Surmodics (SRDX) United States $0.458B 0.00
SNDL (SNDL) Canada $0.405B 0.00
Sanuwave Health (SNWV) United States $0.315B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.314B 0.00
VAREX IMAGING (VREX) United States $0.311B 11.44
Cresco Labs (CRLBF) United States $0.311B 0.00
Capricor Therapeutics (CAPR) United States $0.296B 0.00
Quanterix (QTRX) United States $0.275B 0.00
Aurora Cannabis (ACB) Canada $0.271B 80.17
Cerus (CERS) United States $0.260B 0.00
Viemed Healthcare (VMD) United States $0.249B 20.97
OraSure Technologies (OSUR) United States $0.248B 0.00
Sanara MedTech (SMTI) United States $0.228B 0.00
Canopy Growth (CGC) Canada $0.228B 0.00
Biote (BTMD) United States $0.228B 6.40
Brainsway (BWAY) Israel $0.224B 59.20
Omeros (OMER) United States $0.210B 0.00
Verano Holdings (VRNOF) United States $0.203B 0.00
Organigram Global (OGI) Canada $0.202B 0.00
High Tide (HITI) Canada $0.192B 0.00
Utah Medical Products (UTMD) United States $0.189B 15.52
TriSalus Life Sciences (TLSI) United States $0.177B 0.00
Vireo Growth (VREOF) United States $0.163B 0.00
Exagen (XGN) United States $0.154B 0.00
FitLife Brands (FTLF) United States $0.125B 15.34
TerrAscend (TSNDF) Canada $0.123B 0.00
MacroGenics (MGNX) United States $0.112B 0.00
Jin Medical (ZJYL) China $0.104B 0.00
Fonar (FONR) United States $0.098B 12.70
Quipt Home Medical (QIPT) United States $0.095B 0.00
Jushi Holdings (JUSHF) United States $0.092B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.091B 0.00
Apyx Medical (APYX) United States $0.090B 0.00
Veru (VERU) United States $0.088B 0.00
Safety Shot (SHOT) United States $0.085B 0.00
Zynex (ZYXI) United States $0.077B 0.00
InterCure (INCR) Israel $0.070B 0.00
Agape ATP (ATPC) $0.069B 0.00
Cytosorbents (CTSO) United States $0.063B 0.00
ImmuCell (ICCC) United States $0.061B 0.00
United-Guardian (UG) United States $0.043B 14.92
Modular Medical (MODD) United States $0.039B 0.00
Rockwell Medical (RMTI) United States $0.038B 0.00
Nephros (NEPH) United States $0.036B 49.14
Allurion Technologies (ALUR) United States $0.022B 0.00
INLIF (INLF) $0.015B 0.00
Flora Growth (FLGC) United States $0.014B 0.00
Senestech (SNES) United States $0.013B 0.00
Trinity Biotech (TRIB) Ireland $0.013B 0.00
Meihua Medical Technologies (MHUA) China $0.012B 0.00
IM Cannabis (IMCC) Canada $0.012B 0.00
Cellectar Biosciences (CLRB) United States $0.010B 0.00
Innovative Eyewear (LUCY) United States $0.006B 0.00
Sharps Technology (STSS) United States $0.006B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
Akanda (AKAN) Canada $0.002B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00